Thomas E. Witzig, MD
Mayo Clinic
12
3
11
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+13 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Craig Reeder, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Shaji K. Kumar, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Roy Vivek, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Craig B Reeder, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Rafael Fonseca, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Vivek Roy, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Tanya Trippett, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
All 12 trials loaded